Log In
Print this Print this

vigabatrin (CPP-109)

  Manage Alerts
Collapse Summary General Information
Company Catalyst Pharmaceuticals Inc.
DescriptionIrreversible inhibitor of GABA transaminase
Molecular Target GABA transaminase
Mechanism of ActionGABA transaminase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationTourette's syndrome
Indication DetailsTreat Tourette's disorder
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today